Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Gynecologic Oncology|March 30, 2001
Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancerG Bolis, G Scarfone, G Giardina, et al.Gynecologic Oncology|July 6, 2010
Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9)G Mangili, G Scarfone, A Gadducci, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Potentials of cell kinetics in the management of patients with ovarian cancersR Silvestrini, M G Daidone, B Valentinis, et al.Cancer|January 15, 1998
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocolR Silvestrini, M G Daidone, S Veneroni, et al.European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancerG Bolis, G Scarfone, F Zanaboni, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapyM J Piccart, A Floquet, G Scarfone, et al.British Journal of Cancer|June 13, 2013
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovaryG Mangili, J Ottolina, A Gadducci, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 studyG Mangili, C Sigismondi, D Lorusso, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancerG Bolis, G Favalli, S Danese, et al.European Journal of Cancer (Oxford, England : 1990)|April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)N S Reed, C Mangioni, H Malmström, et al.Pageof 4